Vijaya Diagnostic Centre Limited Appoints Narasimha Raju K A as Chief Financial Officer
Vijaya Diagnostic Centre Limited has appointed Mr. Narasimha Raju K A as its Chief Financial Officer, effective July 09, 2026. The appointment comes in light of his extensive experience in finance, accounting, corporate governance, and strategic leadership across various sectors.The Board of Directors approved the appointment of Mr. Narasimha Raju K A to the role. Mr. Narasimha Raju holds a Chartered Accountant qualification and brings over 20 years of combined experience working in finance, accounting, and corporate strategy. His background includes a strong foundation in Big Four audit at S R Batliboi & Co, an affiliate of Ernst & Young.
In addition to his current appointment, the company noted that Mr. Narasimha Raju previously served as CFO of the company from March 15, 2021, to March 26, 2025. Prior to rejoining the organization, he held the position of Chief Financial Officer at Yashoda Group of Hospitals.
Mr. Narasimha Raju’s career has involved leading complex strategic initiatives for both listed and private equity-backed organizations. His expertise spans several critical areas of corporate finance.
Key details regarding Mr. Narasimha Raju K A's profile include:
| Particulars | Details |
|---|---|
| Role | Chief Financial Officer (CFO) |
| Date of Appointment | July 09, 2026 |
| Qualifications | Chartered Accountant |
| Experience Duration | Over 20 years in finance and corporate governance |
| Core Expertise Areas | Investor relations, stakeholder management, mergers and acquisitions (M&A), private equity, financial reporting (Ind AS and IFRS), Board and Audit Committee governance, tax structuring, budgeting, risk management, and internal controls. |
During his career, Mr. Narasimha Raju has successfully managed high-impact strategic endeavors such as initial public offerings (IPOs) and the preparation of Draft Red Herring Prospectus (DRHP). He is recognized for executing complex capital market transactions within tight timelines and strengthening corporate governance frameworks, including completing the company's IPO during the COVID-19 pandemic.
The management expressed that Mr. Narasimha Raju’s professional acumen and proven leadership in corporate finance are expected to further strengthen the Company’s financial management standards and long term strategic objectives.
VIJAYA Stock Price Movement
Vijaya Diagnostic Centre Limited's shares settled significantly higher today, closing at ₹1377.8 after gaining 4.03% in the post-market session. The stock saw a robust day, finishing near the intraday high of ₹1395.8 amid total traded volume of 249,185 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.